In accordance with [35], the COL5A2 variant identified in the EDS-affected dog from this study is predicted to remove three Gly-Xaa-Yaa triplet repeats and thus induce a structural alteration of the synthesized mutant proα2(V) chains. This evidence concerns the gene COL5A2 and Ehlers-Danlos syndrome.